OR WAIT null SECS
August 02, 2018
Modular manufacturing systems offer a less costly way to increase capacity while reducing time-to-market.
August 01, 2018
CMOs have been active over the past year in expanding their biologics production and capabilities.
This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.
Why shouldn’t biopharmaceutical manufacturers be able to leverage standardized construction practices to improve time to market?
July 19, 2018
The agency has issued a warning letter for cGMP violations at a drug manufacturing facility in Ahmedabad, India, that Baxter gained through its acquisition of Claris Injectables.
July 18, 2018
Modern technologies, including Industry 4.0 and the Industrial Internet of Things, offer opportunities to increase biopharmaceutical manufacturing efficiency.
July 17, 2018
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
July 10, 2018
The expansion at the company’s Gillingham, UK, site, worth EUR 9 million (approximately US$10.5 million), will improve the company’s distribution capabilities.
June 25, 2018
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
June 22, 2018
The company has completed the first phase of expansion at its headquarters in Freiburg, Germany, in anticipation of increasing demand as cell and gene therapies approach commercialization.